HemoQuest provides automated acquisition and classification of leucocyte subtypes and excells through performance, robust autofocus and precise recognition.
HemoFAXS provides excellent performance and security for processing hemograms in the clinical context and is an ideal tool for all types of hematological diseases.
Both RBC and WBC abnormalities are detected, including leukemia type alterations.
Features
HemoFAXS provides not only fully automated acquisition, but also the classifi cation of leukocyte subtypes. Due to the application of the latest Support-Vector-Machine- Technology an especially developed algorithm enables prompt location and classification of leucocytes.
·User friendly
·High speed acquisition
·Acquisition at high resolution (50nm per pixel)
·Increased sharpness by Z-focusing
·Outstanding classifi cation performance
·Patented Support-Vector-Machine Technolog
·Evaluated with cytospins, automatic and manual smears
·Full and easy integration into LIS
·Pay per slide option
·Upgrade from 8 up to 200 slides
·Keep important or interesting analysis
·User adapted interface
·Designed for the customer
·Inspect rare or interesting cells through the ocular after finding them again
Benefits
·Fully automated system
·Can additionaly be used as a classical microscope
·Individual upgrade to customers needs on request
·Cell counting of stained smears whithin a wide variation
·Manual control possible any time
·Intuitive Graphical User Interface (GUI)
·Easy handling
·High accuracy
·Fast acquisition
·Observer independent primary data
·Erythrocyte morphology
·Thrombocyte morphology
·Leukocyte morphology
·Saving of time and resources
·Transfer of results to hospital/laboratory database
bio-equip.cn
TissueGnostics was established in 2003 after nearly a decade of basic research. The goal was to supply scientists with qualitative and observer independent results for cell and tissue analysis in tissue context and this in automated format and significantly less time.
Katja ?sterreicher, Georg Steiner and Dr. Rupert Ecker, the three co-founders of the company, with the aid of a dozen of development partners (Medical University Vienna, Memorial Sloan-Kettering Cancer Center New York, Ludwig Boltzmann Institute for Cancer Research, Vienna; Fred Hutchinson Cancer Center, Seattle; Brighamand Women`s Hospital, Boston; etc.) succeeded in reaching this target by 2005.
Since then TissueGnostics expanded worldwide, with subsidiaries in Romania, the US and more than 15 different distributors (incl. Japan, China, Taiwan, France, Russia, Korea, Australia, Philippines, Great Britain, Italy, Kuwait, etc.). In 2008/2009 TissueGnostics completed its product portfolio with the HemoFAXS, differentiated blood smear analysis system, setting a new standard in blood analysis.
The combination of modern and state-of-the art analysis methods for scientific and clinical use in tissue and cell based research with innovative and easy-to-handle software to ensure efficient and reliable diagnostics always was and will be the motivation behind TissueGnostics product developments.